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We report that delivery of first-generation replication-deficient adenovirus (RDAd) vectors into
primary human fibroblasts is associated with the induction of natural killer (NK) cell-mediated
cytolysis in vitro. RDAd vector delivery induced cytolysis by a range of NK cell populations
including the NK cell clone NKL, primary polyclonal NK lines and a proportion of NK clones (36%)
in autologous HLA-matched assays. Adenovirus-induced cytolysis was inhibited by antibody
blocking of the NK-activating receptor NKG2D, implicating this receptor in this function. NKG2D
is ubiquitously expressed on NK cells and CD8
+ T cells. Significantly, c-irradiation of the vector
eliminated the effect, suggesting that breakthrough expression from the vector induces at least
some of the pro-inflammatory responses of unknown aetiology following the application of
RDAd vectors during in vivo gene delivery.
Replication-deficient adenovirus (RDAd) vectors are used
extensively as vehicles to promote in vivo gene expression
both in experimental animal models and human gene
therapy. However, the administration of RDAd vectors
in vivo is associated with the induction of inflammatory
responses (Schnell et al., 2001), which have resulted in
morbidity and mortality in gene therapy trials (Crystal
et al., 1994; Marshall, 1999; Raper et al., 2003; Schnell
et al., 2001). Although the pro-inflammatory properties of
adenovirus vectors are well documented, the molecular
mechanisms responsible are not fully characterized (Liu
& Muruve, 2003). Immediately following vector delivery, a
transient early inflammatory response can be induced that
is driven by innate mechanisms. This rapid host response
effectively precedes de novo vector-encoded gene expres-
sion, and cannot be eliminated by irradiating RDAd vectors
to render them transcriptionally inactive (Muruve, 2004).
In contrast, delayed host responses tend to be mechanisti-
cally linked with expression from the vector, and may
stimulate both the innate and adaptive immunity.
Whether rapid or delayed, the pro-inflammatory effects
tend to be dose-dependent and associated with the induc-
tion of a wide range of cytokines. Neutrophils, mono-
cytes, macrophages, Kupffer and dendritic cells have all
been implicated as important effector cells in various
model systems (Muruve, 2004).
Whilst the underlying causes are complex, recent studies
indicate that natural killer (NK) cells constitute a key com-
ponent of the response to RDAd vectors in vivo (Marshall,
1999; Ruzek et al., 2002; Xu et al., 2004).
NK cells play a crucial role as a first line of defence against
virus infection, responding to direct intercellular contact
and the cytokine environment. They comprise a hetero-
geneous population, expressing a mosaic of inhibitory and
activating cell-surface NK receptors. The integration of
signals received through these NK receptors engaging their
ligands on potential targets determines the response of
any particular NK cell (Lanier, 2005). The characterization
of NK receptors, in recent years, has provided a detailed
insight into NK recognition. NK receptors belong to either
the immunoglobulin superfamily (IgSF) or the C-type
lectin-like superfamily (LSF). IgSF inhibitory receptors
include the killer cell Ig-like receptors (KIRs) and the
leukocyte Ig-like receptor-1 (LIR-1). KIRs recognize speci-
fic intact HLA-A, -B or -C complexes, whereas LIR-1
interacts broadly with all HLAs (Cosman et al., 1997). LSF
inhibitory receptors include CD94-NKG2A and CD161
(NKR-P1A), recognizing HLA-E and lectin-like transcript-1
(LLT-1), respectively (Aldemir et al., 2005; Rosen et al.,
2005). The IgSF receptors also include a number of 3These authors contributed equally to this work.
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CD112 and CD155, CD96 recognizes CD155, while
CD224 (2B4) recognizes CD48 (Bottino et al., 2003;
Fuchs et al., 2004; Nakajima et al., 1999). The ligands for
NKp30, NKp44, NKp46 and activating KIR isoforms
have yet to be defined. The homodimeric activating
receptor NKG2D recognizes at least seven distinct ligands
(NKG2DL): the MHC class I-related chains MICA, MICB,
UL16-binding proteins (ULBP) 1–3, ULBP4 (RAET1E)
and RAET1G (Bacon et al., 2004; Bauer et al., 1999;
Chalupny et al., 2003; Cosman et al., 2001). This property
renders NKG2D particularly adept at identifying stressed
cells, as its ligands can potentially be differentially upregu-
lated by infection (viral or bacterial), DNA damage or
heat shock (Bauer et al., 1999; Gasser et al., 2005; Groh
et al., 1996, 1998, 2001).
RDAd vectors are an invaluable laboratory tool for
characterizing gene functions and we have exploited them
extensively to analyse NK cell evasion functions (Fooks
et al., 1995; Griffin et al., 2005; Tomasec et al., 2000, 2005;
Wills et al., 2005). RDAd vector systems used to generate
recombinant viruses for these studies were described
elsewhere (He et al., 1998; Wilkinson & Akrigg, 1992),
AdEasy1 vector was kindly provided by Dr B. Vogelstein
(Johns Hopkins University, USA) and pJM17 plasmid-
based vector derived from human adenovirus type 5
(HAdV-5) dl309 was kindly provided by Dr F. Graham
(McMaster University, Canada). Transgenes were inserted
downstream of the human cytomegalovirus major immedi-
ate-early promoter (He et al., 1998; McGrory et al., 1988;
Wilkinson & Akrigg, 1992).
Delivery of either AdEasy1 or pJM17-derived empty con-
trol vector could, in our previous studies, be sufficient by
itself to stimulate killing of human fibroblasts by NK cells,
independent of transgene expression. We set out to
examine the effect of vector infection stimulating NK
cytotoxicity in more detail. Human fetal foreskin fibro-
blasts (HFFF) were used for allogeneic NK cytotoxicity
assays. Primary skin fibroblasts cultured from biopsies
and immortalized using retroviral telomerase (hTERT)
(McSharry et al., 2001) were used for autologous NK
cytotoxicity assays. NK clone NKL (kindly provided by Dr
M. Robertson, Indiana University Medical Center, USA)
was grown in RPMI, 1% human heat-inactivated AB
serum containing 200 U recombinant human interleukin-2
(IL-2) ml
21 (Robertson et al., 1996). Primary polyclonal
NK lines (designated D#NKp, ‘#’ indicates the donor
number) were grown in RPMI supplemented with 5%
human heat-inactivated AB serum and 1000 U IL-2 ml
21,
following depletion of T cells using the OKT3 monoclonal
antibody and Dynabeads. They were regularly co-cultured
with irradiated, allogeneic peripheral blood mononuclear
cells and immortalized B lymphoblastoid cell lines as
feeders. NK polyclonal lines were .95% CD3
2CD56
+ at
use. NK cell cloning was carried out as previously described
(Morris et al., 2005). NK cytotoxicity was measured in
standard 4h
51Cr release assays; the final means and
standard deviations were determined from triplicate or
quadruplicate samples.
RDAd vector delivery to human fibroblast targets repro-
ducibly stimulated cytolysis by polyclonal NK lines from all
donors tested (Fig. 1a). To further investigate the breadth
of the vector effect, we analysed 81 NK clones from three
donors. To be included in analysis, NK clones had to
exhibit cytotoxicity against K562 targets (.10%
51Cr
release). Then, to be scored as responding to RDAd
infection, the NK clone killing had to be either induced or
Fig. 1. Induction of NK cell-mediated cytolysis
following RDAd infection. (a) Susceptibility of
human fibroblasts infected for 72 h with a
control vector with no transgene insertion
(+RDAd) to cell-mediated cytolysis of poly-
clonal NK lines; autologous assays, K562 cells
and mock-infected fibroblasts were used as
cytotoxicity points of reference. (b) Infection of
HFFF with RDAd and not with c-irradiated
RDAd induced NKL killing [72 h post-infection
(p.i.)]. E : T Ratio, effector : target cell ratio. (c)
Susceptibility to NKL cells was not increased
by soluble factors (RDAd-medium) secreted
from infected cells (72 h p.i.). (d) NKG2D
interactions and NKL killing were blocked
efficiently with the anti-NKG2D antibody. (e)
Similar results were observed using polyclonal
NK lines in autologous assays. (f) mRNA levels
of multiple NKG2D ligands were enhanced
following RDAd infection using semiquantita-
tive RT-PCR.
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et al., 1996). The RDAd vector effect on individual NK
cell clones was more variable than on polyclonal lines, yet
activation by RDAd or RDAd–GFP vector delivery was
consistently observed from a large proportion of clones.
Data from a single donor (D8) are shown in Table 1 and
indicate the reproducibility of the effect from clones tested
multiple times. Combining the results from all three
donors, 36% (29 of 81) of NK clones were stimulated upon
encounter with autologous RDAd-infected targets, while
none were inhibited (Table 2). The frequency of clones
stimulated to kill RDAd-infected targets revealed that a
substantial proportion of NK cells were sensitive to this
effector mechanism.
The binding of adenovirus to its cellular receptors and
subsequent uptake by receptor-mediated endocytosis is
known to stimulate intracellular signalling events (Borgland
et al., 2000; Li et al., 1998; Rafii et al., 2001). Specifically,
adenovirus binding with its secondary integrin receptor
during endocytosis is known to induce a transient activa-
tion of NF-kB( B o r g l a n det al., 2000; Philpott et al.,2 0 0 4 ) .
This response was detected in RDAd-infected fibroblasts,
but was short lived and preceded the time points when
NK assays were performed. In vivo pro-inflammatory
effects have also been attributed to breakthrough expres-
sion from first-generation RDAd vectors (Muruve et al.,
2004). GFP-encoding RDAd was c-irradiated with the
minimal dosage required to eliminate transgene expres-
sion, yet still permitted binding and uptake of virus parti-
cles into fibroblasts. The ability of the c-irradiated virus
to retain binding to HFFF was demonstrated by compari-
son of HFFF infected with normal or c-irradiated viruses
labelled with fluorescent DNA dye YOYO-1 (not shown).
The c-irradiated virus lost the capacity to stimulate NKL
killing (Fig. 1b). Priming of NK recognition was therefore
generated by a post-entry event requiring an intact RDAd
vector genome, thus implicating breakthrough expression
from the RDAd vector. Furthermore, conditioned media
from RDAd-infected fibroblasts had no obvious effect in
these assays (Fig. 1c), indicating that vector-induced NK
cell killing was not driven by secreted factors. To investi-
gate the mechanism responsible for vector-induced NK
cell recognition, assays were performed in which char-
acterized NK cell receptor interactions were blocked with
specific antibodies. Indeed, blocking of the NKG2D inter-
actions with its ligands using anti-NKG2D antibody 1D11
(Groh et al., 1998) could reverse the stimulating effect
of RDAd infection upon NKLs (Fig. 1d) or a number
of polyclonal NK lines derived from different donors
(Fig. 1e). Thus, the engagement of NK-activating receptor
NKG2D with its ligands appeared to be a factor in
promoting NK cell lysis of RDAd-infected cells. The NK-
activating receptor NKG2D recognizes at least seven
ligands (as described above), each capable of indepen-
dently activating the NKG2D receptor. When the 6D4
(Groh et al., 1998) antibody to MICA/B was used, it
Table 1. Susceptibility of RDAd-infected cells to NK cell-
mediated lysis
Autologous assays in which values are given as percentage of
51Cr
released±SD. E:T Ratio, effector:target cell ratio.
NK clone E:T Ratio Mock +RDAd +RDAd–GFP K562
D8.NKc1C10* 58:1 48±25 3 ±3 2 63±1
8:1 13±22 1 ±1 2 32±3
27:1 22±2 2 39±1D 56±4
D8.NKc1E11* 21:1 29±23 4 ±1 2 48±4
40:1 10±1 2 33±4D 52±3
23:1 24±11 8 ±1 2 46±5
D8.NKc1F11* 44:1 24±23 8 ±2D 2 52±3
32:1 7±11 9 ±1D 2 31±1
19:1 12±1 2 23±1D 35±1
D8.NKc2F3* 25:1 38±34 5 ±2 2 49±5
20:1 22±1 2 31±33 7 ±2
D8.NKc2G9 5:1 2±13 ±1 2 23±2
D8.NKc3C8* 26:1 8±11 2 ±4 2 29±3
35:1 4±22 4 ±1D 2 40±4
20:1 11±2 2 21±1D 46±3
D8.NKc3D9 11:1 11±11 9 ±3 2 34±3
D8.NKc3E9* 32:1 35±13 1 ±1 2 28±4
18:1 7±1 2 11±13 0 ±3
D8.NKc4F3* 25:1 48±24 0 ±6 2 52±1
10:1 24±1 2 39±1D 61±4
D8.NKc4E10* 44:1 13±32 6 ±3D 2 40±4
23:1 11±23 0 ±3D 2 41±4
20:1 6±1 2 16±2D 30±3
D8.NKc5E7 14:1 7±35 ±3 2 19±2
D8.NKc5C11* 63:1 36±24 3 ±3 2 55±2
66:1 19±23 6 ±3D 2 51±3
50:1 24±3 2 34±3D 59±4
*Multiple assays carried out at different times showing stability of
clonal response.
DIncrease in killing of RDAd-infected cells was greater than 10%.
Table 2. Effect of RDAd infection on cytotoxicity mediated by
individual NK clones derived from multiple donors
Autologous assays; each event represents results obtained from an
individual clone (clones tested more than once were averaged as a
singleevent, some clones were tested against RDAd–GFP, asin Table 1).
Donor RDAd infection
increased lysis*
RDAd infection
inhibited lysis*
RDAd infection
had no effectD
CD94
hi clones
D3 3/4 0/4 1/4
D8d 4/13 0/13 9/13
D9 22/64 0/64 42/64
Total 29/81 (36%) 0/81 52/81 (64%)
*Increase or decrease in cytolysis was greater than 10 %.
DIncrease or decrease in cytolysis was less than 10 %.
dComplete results using this donor are presented in Table 1.
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activation of NK killing (not shown), suggesting that
RDAd infection upregulated multiple NKG2D ligands.
Indeed, semiquantitative RT-PCR analysis of RDAd-
infected cells indicated that the levels of MICA/B and
ULBP1-3 were all enhanced following RDAd infection of
human fibroblasts (Fig. 1f).
This study was instigated in response to an initial observa-
tion that RDAd vector delivery was routinely associated
with enhanced NK cell-mediated killing in in vitro cyto-
toxicity assays. The effect was eliminated by irradiation of
the RDAd vector. NK cell killing was stimulated irrespec-
tive of the transgene encoded by the RDAd vector and in
the absence of transgene, thus indicating that it was
induced by breakthrough expression from the RDAd vector
‘backbone’. The effect could readily be detected in either
an autologous or an allogeneic setting and using a diverse
range of NK cells as effectors, including NKL cells,
expanded NK lines and a substantial proportion of NK
clones tested. The underlying mechanism therefore clearly
affects a high proportion of the effector NK cells. Although
NK cells are a heterogeneous population of cells expressing
a wide variety of activating and inhibitory receptors,
NKG2D is expressed ubiquitously. The level of NKG2DL
expression induced by RDAd vectors was sufficient to
induce a clear dominant activating signal triggering cyto-
lysis in 36% of NK clones tested. The strict requirement for
a change of 10% in the absolute level of cytolysis for a clone
to be scored may well underestimate the level of activation.
Nevertheless, for a substantial proportion of clones, the
upregulation on NKG2DL was not sufficient to override
other inhibitory signals received from the targets.
The in vivo pro-inflammatory properties of adenovirus
vectors can rationally be differentiated into ‘rapid’ effects,
mediated by direct interactions of virus particles, and
‘delayed’ effects, associated with de novo expression from
the vector and/or its transgene. The enhancement of NK
killing of RDAd-infected targets is clearly mediated by
breakthrough expression from the vector, thus its elimina-
tion could be expected to only diminish the delayed res-
ponse. Avoiding vector-associated inflammation is highly
desirable for somatic monogenic replacement therapies;
however, the vast majority of current adenovirus vector
applications are concerned with anti-tumour therapies
or immunization protocols. In such circumstances, the
induction of NK lysis could be postulated to be
therapeutically beneficial in stimulating direct killing or
specific immunity to endogenous tumour- and vector-
expressed antigens. In this context, the delivery of RDAd
vectors lacking an insert or encoding NKG2D ligands have
already been shown to promote tumour cell rejection in
murine models (Friese et al., 2003; Ruzek et al., 2002).
Manipulation of replication-deficient, replication-compe-
tent and/or oncolytic vector systems so as to accentuate
this natural property of the virus to activate NKG2D could
potentially enhance their therapeutic efficacy in certain
circumstances.
Productive virus infections have been reported to activate
the expression of NKG2D ligands; in this context, both
human and murine CMV encode NK evasion functions
that act specifically to combat their induction (Cosman
et al., 2001; Dunn et al., 2003; Lanier, 2005; Welte et al.,
2003). However, RDAd vectors are by definition ‘replica-
tion-deficient’ and their delivery to primary human
fibroblasts is relatively benign, in that they induce neither
‘substantial’ vector-specific gene expression nor a cyto-
pathic effect (Wilkinson & Akrigg, 1992). In this study, the
RDAd vector did not induce a heat-shock response (not
shown) and was associated with only limited perturbation
of NF-kB signalling. The existence of multiple NKG2D
ligands is consistent with a single activating receptor being
sensitive to multiple stimuli. The potential for coordinated
upregulation of multiple NKG2D ligands by vector delivery
was therefore surprising, and suggests that this response
could have evolved to be exquisitely sensitive to detecting
the early phase of virus infection. In this context, it is
important to note that HAdV-5 E1A gene has recently been
shown to upregulate NKG2D ligands via interaction with
p300 (Routes et al., 2005). Since E1A is deleted from all
RDAd vectors used in this study, HAdV-5 must encode
more than one function that activates the expression of
NKG2D ligands.
Antibody-blocking experiments were consistent with the
activation of NKG2D being the primary mechanism
responsible for RDAd-induced NK cell-mediated cytolysis.
Nevertheless, it remains feasible that the RDAd vector may
yet prove capable of stimulating NK recognition by other
means. These issues are currently being addressed. This
study has been concerned with RDAd vector induction
of NK cell recognition; however, it should not be ignored
that human NKG2D is also ubiquitously expressed on
T cells and interferon-producing killer dendritic cells.
NKG2D ligands can substitute for CD28 to act as a co-
stimulatory molecule to promote CD8
+ CTL effector cell
functions and can act in isolation to stimulate cd T cell
function. The activation of NKG2D by RDAd vectors could
therefore be expected to influence T cell responses directly
and also have a profound effect on stimulating both innate
and adaptive immune responses through the release of
cytokines.
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